The rise of antibiotic-resistant bacteria has got many experts predicting a future in which currently tractable diseases, like tuberculosis, became untreatable again. The popularity of modern antibiotics, ironically, is what is leading to their downfall: antibiotics in consumer products, like soaps, as well as the excessive use of antibiotics by people who have no bacterial infections, help select for strains of bacteria that don’t respond to drugs. Factory-farmed livestock, which receive tremendous doses of antibiotics in their feed, are also a likely breeding ground for resistant bacteria that could potentially infect humans.
Proponents of factory farming have scoffed at such claims [pdf], but now, scientists have provided definitive evidence that this happens: through genetic analysis, they found that a strain of MRSA, already resistant to one family of drugs, had hopped from people to farmed pigs, acquired resistance to another antibiotic being fed to the pigs, and then leapt back into humans, taking its new resistance with it. That strain, called MRSA ST398 or CC398, is now causing 1 out of 4 cases of MRSA in some regions of the Netherlands [pdf], where it arose, and it has also been found across the Atlantic in nearly half of the meat in US commerce. After this strain arose in 2004, the European Union began a ban the use of antibiotics in livestock feed. In the United States, however, where most of the antibiotics in circulation are being used in farming, no such regulation exists.
Image courtesy of wattpublishing / flickr
Anyone who’s watched a cat engage in a strenuous butt-licking session only to come over and start in on cleaning up your hand has probably wondered how healthy this can possibly be. Maryn McKenna over at Superbug has uncovered a paper that will probably terrify, but may, with its detailed descriptions of diseases contracted from pets (did you know you can get meningitis from dogs?), fascinate you. From the paper, titled “Zoonoses in the Bedroom”: Read More
What’s the News: Scientists are using nanoparticles to develop ways to fight bacteria that are resistant to conventional antibiotics. These tiny drugs physically punch holes through bacteria instead of killing them chemically, which means that they could be especially effective on antibiotic-resistant bacteria strains like the dangerous methicillin-resistant Staphylococcus aureus (MRSA). “The applications are going to be very diverse, whether we’re talking about wound healing or dressing, skin infection, and quite possibly injections into the bloodstream,” James Hedrick, master inventor at IBM Almaden Research Center in San Jose, California, told Popular Science.